Rouge Therapeutics
- Biotech or pharma, therapeutic R&D
Rouge Therapeutics which is developing novel treatments for Hereditary Hemorrhagic Telangiectasia (HHT)
Address
AmsterdamNetherlands
June 16-19, 2025
Boston Convention & Exhibition Center
Rouge Therapeutics which is developing novel treatments for Hereditary Hemorrhagic Telangiectasia (HHT)